Lifelong restriction of valine — one of three branched-chain amino acids (BCAAs) — in C57BL/6J mice produced a 23% increase in median male lifespan, alongside reductions in frailty, cancer prevalence, and senescent cell burden in both sexes. Crucially, Val-R mice maintained greater leanness and glycemic control across all ages tested. Transcriptomic analysis across tissues pinpointed a liver gene module enriched in mitochondrial pathways, corroborated by directly measured increases in mitochondrial respiration in Val-R males — suggesting the longevity signal flows through enhanced mitochondrial function rather than simple caloric dilution.
This finding is genuinely significant for the aging field. Prior work from this Wisconsin group and others established that total protein restriction or full BCAA restriction extends mouse healthspan, but isolating valine as a sufficient driver is mechanistically clarifying. It narrows the target considerably — valine competes with other large neutral amino acids for brain transport and is a key mTORC1 activator, making it a credible node for metabolic reprogramming. The sex-specific lifespan extension (males only, despite shared healthspan benefits) echoes patterns seen with rapamycin and caloric restriction, hinting at hormonal or sex-chromosomal modulators still unresolved. Practical translation remains distant: self-imposing valine restriction through diet is difficult without precise food engineering, and mouse-to-human extrapolation for longevity claims is notoriously unreliable. Still, this is more than incremental — it opens a tractable pharmacological target for mimicking BCAA sensing pathways in humans.
